Employer record · Cranbury, NJ · FY2020–FY2025

Exemplify BioPharma, Inc.

    Certified LCAs
    3
    FY2024–FY2026
    USCIS approvals
    3
    1 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $115k
    certified LCAs

    Jobs not indexed yet

    Does Exemplify BioPharma, Inc. sponsor H-1B visas?

    Yes — by its record, Exemplify BioPharma, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Sep 26, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 8 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Exemplify BioPharma, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2011100%
    FY2221100%
    FY2322100%
    FY2531100%
    FY2602100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Chemists 19-20312$110k
    Medical Scientists, Except Epidemiologists 19-10421$120k

    Most-filed job titles

    1. Senior Drug Product Analytical Chemist1$115k
    2. Senior Formulation Scientist1$120k
    3. Senior Research Chemist1$104k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New Jersey3 LCAs

    We haven't indexed Exemplify BioPharma's jobs yet

    We read jobs straight from employers' own career sites and haven't added Exemplify BioPharma's yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • EXEMPLIFY BIOPHARMA INC (USCIS)
    • Exemplify BioPharma, Inc. (LCA)

    Exemplify BioPharma, Inc. H-1B: questions people ask

    Does Exemplify BioPharma, Inc. sponsor H-1B visas?

    Yes — by its record, Exemplify BioPharma, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Sep 26, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Exemplify BioPharma, Inc. still sponsoring H-1B in 2026?

    Exemplify BioPharma, Inc. had 0 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 3 in FY2025. The latest one in our data was decided Sep 26, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Exemplify BioPharma, Inc. get approved?

    USCIS recorded 3 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Exemplify BioPharma, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Exemplify BioPharma, Inc.?

    The median wage offered on Exemplify BioPharma, Inc.'s certified LCAs in FY2024–FY2026 was $115k a year. By job title: Senior Drug Product Analytical Chemist $115k (1 LCAs), Senior Formulation Scientist $120k (1 LCAs) and Senior Research Chemist $104k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Exemplify BioPharma, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Chemists (2) and Medical Scientists, Except Epidemiologists (1).

    Where are Exemplify BioPharma, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New Jersey (3).

    Is Exemplify BioPharma, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Exemplify BioPharma, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Exemplify BioPharma's yet.